HIV & Pediatrics 2019 – Presentations

 

Friday 19 July 2019

 Session 1: Global Update on Pediatric HIV
 

2019 Update on the HIV Epidemic in Infants, Children, Adolescents and Women 
Mary Mahy, ScD, MHSc
UNAIDS, Switzerland

 What's New from WHO on Pediatric Antiretroviral Therapy
(Not yet available)
Martina Penazzato
WHO, Switzerland
 Population HIV Impact Assessments: What We Can Learn About Pediatric HIV
(Not yet available)
Suzue Saito, PhD
ICAP at Columbia University, USA
 Discussion
 Session 2: Pediatric Care and Treatment
 

Long-Acting and Innovative Formulations and Drug Delivery Devices: Possibilities for Children and Adolescents 
Charles Flexner, MD
Johns Hopkins Hospital, USA

 

Finding Kids, Treating Kids: Innovations in Case-Finding, Treatment and Care
Saeed Ahmed, MD, BA
Baylor College of Medicine, Malawi

 Oral Abstract Presentations
 Community Based Index- and Mobile Testing are Complementary and Effective in Pediatric HIV Case Finding in Tanzania
Jemma Bisimba, Tanzania
 #01
 The Cost-Effectiveness of Point-of-Care Platforms for Early Infant Diagnosis of HIV Infection in Southern Province, Zambia
Catherine Sutcliffe, USA
 #02
 Virological Outcomes and ART Discontinuation in Children Switching to Dolutegravir in The UK/Ireland: A Propensity Score Analysis
Siobhan Crichton, United Kingdom
 #03
 Tenofovir Alafenamide-Based Regimens: A Pooled Resistance Analysis in Pediatric Participants
Stephanie Cox, USA
 #04
 Population Pharmacokinetics of Nevirapine in Preterm Infants and Prediction of Doses Needed For Treatment in Combination with other Antiretrovirals
(Not yet available)

Adrie Bekker, South Africa
 #05
 Session 3: Comorbidities/Infections
 Oral Abstract Presentations
 Systemic Inflammation and Structural Brain Changes in Perinatally HIV+ Adolescents
Jackie Hoare, South Africa
 #06
 Associations Between Cholesterol, Apolipoprotein E Genotype Variants, Cognition and Brain Structure in Perinatally HIV+ Adolescents
Jackie Hoare, South Africa
 #07
 Malignancies in Children With HIV Across Eastern and Western Europe and Thailand
Elizabeth Chappel, USA
 #08
 Shorter Telomeres Among HIV+ Cart-Naïve and Cart-Treated Children, and Those Presenting with Abnormal Lung Function
Louis-Marie Yindom, UK
 #09
 Atazanavir Exposure in Utero and Risk of Multiple Signals of Neurodevelopmental Dysfunction in 5-Year-Old HIV-Exposed Uninfected Children
(Not yet available)

Tzy-Jyun Yao, USA
 #10
  
 Clinical Case Presentations
(Not yet available)

Moderators: Gareth Tudor Williams and Noris Pavia-Ruz
 Theodore Ruel
(Not yet available)
University of California San Francisco, USA
 Jorge Pinto, MD, DSc
(Not yet available)
Federal University of Minas Gerais, Brazil
 Denis Tindyebwa , MBChB, MMed
(Not yet available)
African Network for the Care of Children Affected by HIV/AIDS (ANECCA), Uganda
  
 Short Oral Poster Presentations
 The Clinical Impact and Cost-Effectiveness of Routine HIV Screening and Testing at Infant Immunization Visits in Côte d’Ivoire (CI), South Africa, and Zimbabwe
Andrea Ciaranello, USA
 #21
 Safety and Efficacy of E/C/F/TAF In Virologically Suppressed, HIVInfected Children Through 96 Weeks
Natella Rakhmanina, USA
 #22
 Neurodevelopmental Outcome at 11 Months in Perinatally HIV-Infected Infants: Does Starting Very Early Antiretroviral Therapy Help?
Barbara Laughton, South Africa
 #23
 T Cell Senescence and Exhaustion In Perinatally HIV Infected Children (PHIC)
Beatriz Thome, Brazil
 #24
  
 

Saturday 20 July 2019

 SPECIAL SESSION: Tsepamo Update  
Rebecca Zash

 

Rebecca Zash, MD
(Not yet available)

Harvard University, USA

Mimi Raesima, MD
(No permission given to publish slides or video)

CDC, Botswana

 Session 4: Prevention of New Pediatric HIV Infections and Improving Maternal Health
 

Update on Preconception ARVs and Birth Defects  
Claire Thorne, PhD
University College London, UK

 Oral Abstract Presentations
 Periconceptional Antiretroviral Exposure and Central Nervous System (CNS) and Neural Tube Birth Defects – Data from Antiretroviral Pregnancy Registry (APR)
Lynne Mofenson, USA
 #12
 Effects Of Dolutegravir and Other Integrase Inhibitors on Folate Transport Pathways
Maciej Zamek-Gliszczynski, USA
 #13
 HIV Drug Resistance at Mother-To-Child Transmission and Emergence During Breastfeeding
Ceejay Boyce, USA
 #14
 Lower Birth Weight-for-Age And Length-for-Age Z-Scores In Infants with In Utero HIV and ARV Exposure: A Prospective Study In Cape Town, South Africa
Dorothy Chiwoniso Nyemba, South Africa
 #15
  
 Addressing Sexual and Reproductive Health Needs for Adolescent and Young Women in Low- and Middle-Income Countries
(Not yet available)
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP (SA), PhD
Desmond Tutu HIV Center, South Africa
 Short Oral Poster Presentations
 Chronic Maternal Depression Symptomatology Predicts Executive Behavioral Problems in HIV Affected Children in Uganda
Itziar Familiar, USA
 #25
 Age- and Site-Specific Trends in Advanced HIV Disease At Antiretroviral Therapy Initiation Among HIV-Infected Children in Eastern And Southern Africa: 2003-20177
(Not yet available)
Peter Elyanu, Uganda
 #26
 Closing the Treatment Gap For Children: Global and Regional Trends in Pediatric Antiretroviral Therapy Coverage, 2010-2017
Joseph Gregory Rosen, Zambia
 #27
 Outcomes of Children and Adolescents Living With HIV Considered Lost to Follow Up at IeDEA-SA Cohorts in the Western Cape: Linkage to Western Cape Provincial Health Data Centre Records.
Patience Nyakato, South Africa
 #28
  
 Session 5: Adolescents and Young Adults
 

DEBATE: Transition to Adult Care is Bad for the Health of HIV-Positive Youth  

Rachel Vreeman, MD, MS - Pro standpoint
Icahn School of Medicine at Mount Sinai, USA

vs.

Hilda Mujuru, MBChB, MMed Paeds, MSc Clin Epi
(Not yet available) 
University of Zimbabwe, Zimbabwe

 Oral Abstract Presentations
 High Uptake and Completion of HIV Self-Testing Using a Novel Community based Delivery System for Young People in Kenya
(Not yet available)

Kate Wilson, USA
 #16
 Describing The Characteristics and Long-Term Outcomes of Adolescents Living with Perinatally Acquired HIV in the IeDEASouthern Africa Collaboration: 2004-2017
Priscilla Tsondai, South Africa
 #17
 Growth and Immunodeficiency of ART-Treated Adolescents Living with Perinatally Acquired HIV: A Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration Analysis.
Julie Jesson, France
 #18
 Hospitalization in Perinatally HIV-Infected Adolescents on Antiretroviral Therapy in South Africa: A Prospective Study.
Lisa Frigati, South Africa
 #19
 The Next Generation: Pregnancy Outcomes in Adolescents and Women Living With Perinatally Acquired HIV in South Africa
Kim Anderson, South Africa
 #20
  
 State of ART: Prevention of HIV in Adolescent and Young MSM
(Not yet available)

Nittaya Phanuphak, MD, PhD
Thai Red Cross AIDS Research Center 
 State of ART: Prevention of HIV in Adolescent and Young Women
Quarraisha Abdool Karim, PhD
CAPRISA, South Africa